A Multi-Center, Randomized, Controlled Cross-Over Study to Evaluate the Safety and Effectiveness of Hypoxic Red Blood Cells Processed with the Hemanext ONE® System versusConventional Red Blood Cells in Patients with Transfusion-Dependent Haematologi